No ROS1 rearrangements were detected in this study, which can be explained by the epidemiological and clinico-pathological characteristics of our series together with the low prevalence of ROS1 rearrangement reported in NSCLC [43,44]. Here, ROS1 is linked to non-small cell lung carcinoma.